Ibrutinib enhances the efficacy of ROR1 bispecific T cell engager mediated cytotoxicity in chronic lymphocytic leukaemia.
Satyen H GohilRachel EvansMicaela HarasserMohamed El-KholySolange R Paredes-MoscossoMarco Della PerutaAmit C NathwaniPublished in: British journal of haematology (2019)
Keyphrases